Women can reduce their risk for womb cancer by eating a Mediterranean diet
the ONA take:
An Italian research team has found that women who eat a Mediterranean diet reduce their risk of womb cancer (endometrial cancer) by more than half.
The researchers reviewed the diets of more than 5,000 women, and measured how the women followed each of nine different components of a Mediterranean diet.
The components included eating lots of vegetables, fruits and nuts, pulses, cereals and potatoes, fish, monounsaturated fats but little meat, milk and other dairy products, and moderate alcohol intake.
The women who adhered most closely to diet reduced their risk by the greatest percentage. Following seven to nine of the components reduced risk of womb cancer by 57%, following six components reduced risk by 46%, and following five components reduced risk by 34%. Following fewer than five components did not significantly reduce a woman’s risk for womb cancer.
Women who eat a Mediterranean diet reduce their risk of womb cancer (endometrial cancer) by more than half.
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Compound in Teas, Peas, Soybeans May Increases Prostate Cancer Risk
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- A Case of Immunotherapy-Induced Myocarditis Concomitant to MG in Lung Cancer
- Duloxetine May Improve AI-Associated Joint Pain in Early Stage Breast Cancer
- Axillary Lymph Node Dissection Predictive for Lymphedema in Breast Cancer
- Vitamin D Supplementation is Recommended for Pediatric Patients With Sarcoma
- Extended Adjuvant Therapy for Breast Cancer Improves 5-Year Disease-free Survival
- A Structured Group Exercise Program for Patients With Metastatic Cancer Receiving Chemotherapy and CTNNB1 (β-catenin) as a Biomarker of Exercise Efficacy
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|